Download PDF
Open Access
CC BY-NC-ND 4.0 · Sleep Sci 2020; 13(03): 210-213
DOI: 10.5935/1984-0063.20200055
CASE REPORT

Effectiveness of a brief behavioral intervention for insomnia (BBII) during the COVID-19 pandemic: Mexican case report

Authors

  • Horacio Balam Álvarez-García

    1   National Autonomous University of Mexico, Sleep Disorders Clinic, Medicine Faculty, Research Division - Mexico City - Mexico.

  • Ulises Jiménez-Correa

    1   National Autonomous University of Mexico, Sleep Disorders Clinic, Medicine Faculty, Research Division - Mexico City - Mexico.
    2   National Autonomous University of Mexico, Postgraduate program in Behavioral Neuroscience, Psychology Faculty - Mexico City.

  • Katie Moraes de Almondes

    3   Onofre Lopes University Hospital, AMBSONO Sleep Clinic - Natal - Rio Grande do Norte - Brazil.
    4   Federal University of Rio Grande do Norte, Department of Psicobiología and Postgraduate Program in Psicobiología - Natal - Rio Grande do Norte - Brazil.
Further Information
Also available at
  Permissions and Reprints

This report describes a case of a 42-year-old man. Due to overwork, initially has developed insufficient sleep syndrome; and later insomnia that temporarily coincided with the COVID-19 pandemic. A brief behavioral intervention for insomnia (BBII) was implemented that included: sleep restriction therapy (SRT), stimulus control therapy (SCT), sleep hygiene, and progressive muscle relaxation (PMR). The intervention was designed as five weekly sessions; nevertheless, it should be mentioned that starting with the third consultation, telepsychology was started due to the recommendations for social isolation implemented by the COVID-19 pandemic. At the end of treatment, the patient increased time and subjective sleep quality. Despite the social distancing measures (which started in the middle of the treatment), the patient had recovery of the sleep quality, highlighting the importance of implementing the telepsychology during the COVID-19 quarantine.

Sleep Initiation and Maintenance Disorders - Cognitive Behavioral Therapy - Pandemics - Coronavirus - Psychotherapy - Brief - Case Reports


Publication History

Received: 18 June 2020

Accepted: 04 September 2020

Article published online:
09 November 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • REFERENCES

  • 1 American Academy Sleep Medicine (AASM). International classification of sleep disorders (ICSD-3). 3rd ed. Darien, IL: AASM; 2014.
  • 2 Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987 Dec;10(4):541-53.
  • 3 Altena E, Baglioni C, Espie CA, Ellis J, Gavriloff D, Holzinger B, et al. Dealing with sleep problems during home confinement due to COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy. J Sleep Res. 2020 Apr;e13052.
  • 4 Morin CM, Jarrin DC. Epidemiology of insomnia. Sleep Med Clin. 2013;8(3):281-97.
  • 5 Bouscoulet LT, Vazquez-Garcia JC, Muiño A, Marquez M, López MV, Oca MM, et al. Prevalence of sleep related symptoms in four Latin American cities. J Clin Sleep Med. 2008;4(6):579-85.
  • 6 Baglioni C, Altena E, Bjorvatn B, Blom K. The European academy for cognitive behavioural therapy for insomnia: an initiative of the European insomnia network to promote implementation and dissemination of treatment. J Sleep Res. 2020 Apr;29(2):e12967.
  • 7 Morin C. Cognitive-behavioral therapy of insomnia. Sleep Med Clin. 2006 Sep;1(3):375-86.
  • 8 Riemann D, Baglioni C, Basetti C, Bjorvatn B, Groselj LD, Ellis J, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017 Dec,26(6):675-700.
  • 9 Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008 Oct;4(5):487-504.
  • 10 Cheung JMY, Jarrin DC, Ballot O, Bharwani AA, Morin CM. A systematic review of cognitive behavioral therapy for insomnia implemented in primary care and community settings. Sleep Med Rev. 2019 Apr;44:23-36.
  • 11 Germain A, Buysse D. Brief behavioral treatment of insomnia. In: Perlis M, Aloia M, Kuhn B, eds. Behavioral treatments for sleep disorders. A comprehensive primer of behavioral sleep medicine interventions. San Diego: Elsevier Inc.; 2011. p. 143-50.
  • 12 McCrae CS, Bramoweth AD, Williams J, Roth A, Mosti C. Impact of brief cognitive behavioral treatment for insomnia on health care utilization and costs. J Clin Sleep Med. 2014 Feb;10(2):127-35.
  • 13 Jiménez-Genchi A, Monteverde-Maldonado E, Nenclares-Portocarrero A, Esquivel-Adame G, Vega-Pacheco A. Confiabilidad y análisis factorial de la versión en español del índice de calidad de sueño de Pittsburgh en pacientes psiquiátricos. Gac Méd Méx. 2008;144(6):491-6.
  • 14 Nenclares-Portocarrero A, Jimenez-Genchi A. Estudio de validación de la traducción al español de la escala atenas de insomnio. Salud Mental. 2005 Oct;28(5):34-9.
  • 15 Pottie K, Thompson W, Simon D, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018 May;64(5):339-51.
  • 16 Troxel W, Germain A, Buysee D. Clinical management of insomnia with brief behavioral treatment (BBTI). Behav Sleep Med. 2012;10(4):266-79.
  • 17 Gunn H, Tutek J, Buysse D. Brief behavioral treatment of insomnia. Sleep Med Clin. 2019 Jun;14(2):235-43.